Key clinical point: Radiofrequency ablation of small renal tumors is safe and effective.
Major finding: In 106 patients with small renal masses, disease-free survival was 89% at 6 years post procedure.
Study details: Retrospective cohort study of 106 patients with 112 tumors, followed up to 10 years.
Disclosures: The authors reported no conflicts of interest and no outside sources of funding.
Source: Johnson B et al. J Urol. 2018. doi: 10.1016/j.juro.2018.08.045.
Johnson B et al. J Urol. 2018. doi: 10.1016/j.juro.2018.08.045
This Week's Must Reads
Must Reads in Renal Cell Carcinoma
First-line avelumab/axitinib for RCC benefits wide range of patients, Choueiri TK et al. GUCS 2019, Abstract 544.
Strong link found between RCC and melanoma, Kim KB et al. Cancer Epidemiol. 2018 Oct 19;57:80-4
Apo B/A1 predicts survival in metastatic renal cell carcinoma, Zhang F et al. Urol Oncol. 2018 Nov 30. doi: 10.1016/j.urolonc.2018.11.010